HomeTRVI • NASDAQ
add
Trevi Therapeutics Inc
Previous close
$10.70
Day range
$10.37 - $11.08
Year range
$4.85 - $14.39
Market cap
1.36B USD
Avg Volume
1.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.22M | -16.52% |
Net income | -8.32M | 27.15% |
Net profit margin | — | — |
Earnings per share | -0.06 | 45.45% |
EBITDA | -10.19M | 16.52% |
Effective tax rate | 0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 188.26M | 74.93% |
Total assets | 193.44M | 74.43% |
Total liabilities | 10.20M | -9.43% |
Total equity | 183.24M | — |
Shares outstanding | 128.40M | — |
Price to book | 7.48 | — |
Return on assets | -13.01% | — |
Return on capital | -13.64% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.32M | 27.15% |
Cash from operations | -7.63M | 20.09% |
Cash from investing | -30.61M | -28.22% |
Cash from financing | 284.00K | -99.45% |
Net change in cash | -37.96M | -310.34% |
Free cash flow | -4.31M | 18.26% |
About
Founded
2011
Headquarters
Website
Employees
34
